当前位置: 首页 > 详情页

Pituitary tumor-transforming gene 1 regulates invasion of prostate cancer cells through MMP13

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ China, Beijing Anzhen Hosp, Dept Urol, 2 Anzhen Rd, Beijing 100029, Peoples R China; [2]Chinese Acad Sci, Inst Biophys, Beijing 100864, Peoples R China
出处:
ISSN:

关键词: Prostate cancer (PC) Pituitary tumor-transforming gene 1(Pttg1) Cancer metastasis Matrix metalloproteinase 13 (MMP13) PI3k/Akt signaling pathway

摘要:
It is critical to understand the molecular mechanisms underlying the migration and invasiveness of prostate cancer (PC) for improving the outcome of therapy. A relationship of pituitary tumor-transforming gene 1 (Pttg1) and matrix metalloproteinase 13 (MMP13) in PC as well as their roles in the metastases of PC has not been studied. Here, we reported significantly higher levels of Pttg1 and MMP13 in the resected PC specimens, compared to the adjacent normal prostate tissue from the same patient. Interestingly, Pttg1 and MMP13 levels strongly correlated with each other. In vitro, Pttg1 activated MMP13, which determined PC cell invasiveness. However, Pttg1 levels were not significantly affected by MMP13. Furthermore, the Pttg1-activated MMP13 in PC cells was significantly suppressed by inhibition of PI3k/Akt, but not ERK/MAPK or JNK pathways. Together, our data suggest that Pttg1 may increase PC cell metastasis by MMP13, and highlight Pttg1/MMP13 axis as a promising therapeutic target for PC treatment.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
JCR分区:
出版当年[2014]版:
Q2 ONCOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Capital Med Univ China, Beijing Anzhen Hosp, Dept Urol, 2 Anzhen Rd, Beijing 100029, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ China, Beijing Anzhen Hosp, Dept Urol, 2 Anzhen Rd, Beijing 100029, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院